Please use this identifier to cite or link to this item:
http://dr.iiserpune.ac.in:8080/xmlui/handle/123456789/1587
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Sharma, Kavita | en_US |
dc.contributor.author | Iyer, Aishwarya | en_US |
dc.contributor.author | SENGUPTA, KUNDAN | en_US |
dc.contributor.author | CHAKRAPANI, HARINATH | en_US |
dc.date.accessioned | 2019-02-14T05:00:09Z | |
dc.date.available | 2019-02-14T05:00:09Z | |
dc.date.issued | 2013-06 | en_US |
dc.identifier.citation | Organic Letters, 15(11), 2636-2639. | en_US |
dc.identifier.issn | 1523-7060 | en_US |
dc.identifier.issn | 1523-7052 | en_US |
dc.identifier.uri | http://dr.iiserpune.ac.in:8080/xmlui/handle/123456789/1587 | - |
dc.identifier.uri | https://doi.org/10.1021/ol400884v | en_US |
dc.description.abstract | The design, synthesis, and development of INDQ/NO, a novel nitric oxide (NO) prodrug targeted by a bioreductive trigger, are described. INDQ/NO, an indolequinone-diazeniumdiolate is found to be metabolized to produce NO by DT-diaphorase, a bioreductive enzyme that is overexpressed in certain cancers and hypoxic tumors. Cell-based assays revealed that INDQ/NO induces DNA damage and is a potent inhibitor of cancer cell proliferation. | en_US |
dc.language.iso | en | en_US |
dc.publisher | American Chemical Society | en_US |
dc.subject | INDQ/NO | en_US |
dc.subject | Bioreductively | en_US |
dc.subject | Nitric Oxide Prodrug | en_US |
dc.subject | Tumoristatic agent | en_US |
dc.subject | Two-electron reductase | en_US |
dc.subject | Reactive nitrogen | en_US |
dc.subject | 2013 | en_US |
dc.title | INDQ/NO, a Bioreductively Activated Nitric Oxide Prodrug | en_US |
dc.type | Article | en_US |
dc.contributor.department | Dept. of Chemistry | en_US |
dc.identifier.sourcetitle | Organic Letters | en_US |
dc.publication.originofpublisher | Foreign | en_US |
Appears in Collections: | JOURNAL ARTICLES |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.